skip to main content

Main Site Navigation

Top of main content

Clinical Trials Details

AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH

Location: Carle - Digestive Health Center
Body site or condition: Gastrointestinal - Colon/Rectal
Department: Digestive Health

3152-301-002 | 18DHI1863

The AURORA study will be conducted to confirm the efficacy and safety of cenicriviroc (CVC) for the treatment of liver fibrosis in adult subjects with NASH.

Apply Now